National COVID-19 Clinical Evidence Taskforce – launch of clinical guidelines

The National COVID-19 Clinical Evidence Taskforce, which ACRRM is a part of,  has launched the new “living guidelines”. These guidelines will provide evidence-based guidance to clinicians caring for people with COVID-19.

The Taskforce is working to transform emerging research and data into accessible, evidence-based guidelines for the clinical management of COVID-19 across primary, acute and critical care settings.

The guidelines will constantly be updated to ensure clinicians have access to reliable, up-to-date guidance during this unprecedented health crisis and will form a key part of Australia’s response to COVID-19. They are available here: www.covid19evidence.net.au 

The initial focus of the guidelines will be on

• Definitions of disease severity
• Monitoring and markers of clinical deterioration
• Antiviral medications and other disease modifying treatments
• Respiratory support

The Taskforce is now working weekly with its members, partners and other stakeholders to monitor emerging evidence and expand the scope of the guideline recommendations in response to the most pressing needs of clinicians seeking to provide the best possible care during the pandemic.